C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling

  • J. Lim, A. Iyer, J. Y. Suen, V. Seow, R. C. Reid, L. Brown, D. P. Fairlie
  • The FASEB Journal, November 2012, Federation of American Societies For Experimental Biology (FASEB)
  • DOI: 10.1096/fj.12-220582

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1096/fj.12-220582